NEW YORK, March 19 - Geospiza on Tuesday said that the US National Institutes of Health has awarded it $1.1 million to "re-engineer" its Phrap gene-sequencing technology.
Geospiza and its research partner Southwest Parallel Software will use the cash to "improve Phrap's ability to use external information" to help researchers assemble gene sequences. These modifications will make the technology "better suited for high-throughput data processing," Geospiza said.
Phrap-based research has over the past few years expanded to include SNP and mutation discovery, expression analysis, bacterial sequencing, and confirmatory sequencing, the company said in a statement.
"Phrap was originally developed with a more narrow focus as a tool to assist genome centers sequencing cosmids," Todd Smith, president of Geospiza, said in the statement. "But people are using Phrap for new things now and the applications for [it] have increased...."